Published on in Vol 8, No 1 (2022): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31576, first published .
Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)

Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)

Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)

Erin L Van Blarigan   1, 2 , ScD ;   Anand Dhruva   3, 4, 5 , MD ;   Chloe E Atreya   4, 5 , MD, PhD ;   Stacey A Kenfield   1, 2 , ScD ;   June M Chan   1, 2 , ScD ;   Alexandra Milloy   5 , BS ;   Iris Kim   6 ;   Paige Steiding   5 , BS ;   Angela Laffan   5 , NP ;   Li Zhang   1, 4 , PhD ;   Sorbarikor Piawah   4, 5 , MPH, MD ;   Yoshimi Fukuoka   7 , RN, PhD ;   Christine Miaskowski   7 , RN, PhD ;   Frederick M Hecht   3, 4 , MD ;   Mi-Ok Kim   1, 5 , PhD ;   Alan P Venook   4, 5 , MD ;   Katherine Van Loon   4, 5 , MPH, MD

1 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States

2 Department of Urology, University of California, San Francisco, San Francisco, CA, United States

3 Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, United States

4 Department of Medicine, University of California, San Francisco, San Francisco, CA, United States

5 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States

6 University of California, Berkeley, Berkeley, CA, United States

7 School of Nursing, University of California, San Francisco, San Francisco, CA, United States

Corresponding Author:

  • Erin L Van Blarigan, ScD
  • Department of Epidemiology and Biostatistics
  • University of California, San Francisco
  • UCSF Box 0560, 550 16th St. 2nd Floor
  • San Francisco, CA, 94158
  • United States
  • Phone: 1 415 476 1111 ext 13608
  • Email: erin.vanblarigan@ucsf.edu